News
Thermo Fisher Scientific further strengthen its Global Response to COVID-19 to Support Development and Production of Therapeutics and Vaccines
Thermo Fisher Scientific, the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines,...
News
Synairgen Releases Positive Results from Breakthrough Coronavirus Treatment
Synairgen, the respiratory drug discovery and development company which originated from research at the University of Southampton, has released positive results from its clinical trial of SNG001, its wholly-owned inhaled formulation of interferon beta, in hospitalized COVID-19 patients.
"We are...
News
Gemini Bio Launches the Moxi V Cell Analyzer
Gemini Bioproducts, LLC, a leading supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, announced the launch of the Moxi V™ for precision cell analysis.
The Moxi V™ utilizes the Coulter Principle to precisely measure cell...
News
Bora strengthens commercial team ahead of North American facility acquisition
Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO) which specializes in immediate and modified release tablets and capsules, along with serialized packaging, has announced the appointment of four business development directors to its commercial teams in the...
News
CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
CURE Pharmaceutical, an innovative drug delivery and development company, announced that its 25mg cannabidiol (CBD) oral thin film (OTF) showed improved bioavailability of cannabidiol in healthy subjects, compared with 25mg soft gels. Specifically, a pharmacokinetic (PK) study in 14...
Clinical Trials
Oxford COVID-19 Vaccine Shows Promise In Early Testing: Study
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.
The vaccine, called AZD1222 and being developed by pharmaceutical company AstraZeneca...
News
Oxford University Covid-19 vaccine raises hopes with strong trial results
Researchers at the University of Oxford believe they may have a breakthrough in their search for a Covid-19 vaccine after the team discovered that the jab could provide "double protection" against the deadly coronavirus following early stage human trials,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read